- Home
- PRME vs HAFC Comparison
PRME vs HAFC Comparison
Compare PRME & HAFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PRME | HAFC |
|---|---|---|
| Founded | 2019 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 666.1M | 770.0M |
| IPO Year | 2022 | 2000 |
Fundamental Metrics
Financial Performance| Metric | PRME | HAFC |
|---|---|---|
| Price | $3.56 | $25.38 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 6 | 3 |
| Target Price | $7.56 | ★ $31.33 |
| AVG Volume (30 Days) | ★ 2.6M | 199.0K |
| Earning Date | 03-03-2026 | 04-21-2026 |
| Dividend Yield | N/A | ★ 4.36% |
| EPS Growth | 18.18 | ★ 22.44 |
| EPS | N/A | ★ 2.51 |
| Revenue | $4,632,000.00 | ★ $270,165,000.00 |
| Revenue This Year | $15.20 | $18.65 |
| Revenue Next Year | $316.23 | $7.28 |
| P/E Ratio | ★ N/A | $10.25 |
| Revenue Growth | ★ 55.28 | 15.28 |
| 52 Week Low | $1.11 | $19.25 |
| 52 Week High | $6.94 | $30.20 |
Technical Indicators
Market Signals| Indicator | PRME | HAFC |
|---|---|---|
| Relative Strength Index (RSI) | 43.03 | 41.66 |
| Support Level | $3.19 | $24.44 |
| Resistance Level | $4.74 | $25.57 |
| Average True Range (ATR) | 0.26 | 0.65 |
| MACD | -0.05 | 0.02 |
| Stochastic Oscillator | 9.46 | 35.85 |
Price Performance
Historical ComparisonAbout PRME Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.
About HAFC Hanmi Financial Corporation
Hanmi Financial Corp is a Los Angeles-based bank that caters to Korean-Americans and other multi-ethnic communities across California, Colorado, Georgia, Illinois, New Jersey, New York, Texas, Virginia, and Washington. The bank mainly focuses on small businesses and commercial and real estate loans. It also offers a variety of international finance and trade services and products, including letters of credit, import financing, and export financing. The Bank's revenues are derived from interest and fees on loans, interest, and dividends on the securities portfolio, service charges on deposit accounts, and sales of SBA loans.